Floatz logo

Neocartilage Implant/Denovo® Et

Articular Cartilage Disorder

ISTO Technologies, Inc.Cell therapyPhase 3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Articular Cartilage Disorder cohort.

Asset / SponsorPhaseRating
Oxygen
Jay C. Buckey Jr.
Phase 4BB
Neocartilage Implant/Denovo® Et
ISTO Technologies, Inc.
Phase 3B

Same molecule, other indications

Neocartilage Implant/Denovo® Et is also rated in:

articular cartilage disorderDormant
B
Indicative ·
57 / 100
View asset →
osteoarthritis, kneeDormant
B
Indicative ·
57 / 100
View asset →
Acute Cartilage InjuryDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →